Large-Scale Prospective Virtual Screening Using a Co-Folding-Rescoring Workflow for NPM1-TYK2 Inhibitor Discovery.
Source check: Needs source check. Not independent scientific confirmation.
Finding / tested result: Prospective screening yielded an experimentally active TYK2 hit and a more potent analog.
Technology: AlphaFold 3 learned co-folding with Vina rescoring
Family AlphaFold 3: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- AlphaFold 3 learned co-folding with Vina rescoring is the AI method documented in the editorial source review.
- Limitation / still unknown
- The date refers to the cited version. Earlier public versions and independent replication were not systematically verified.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3390/ijms27219864
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.